Development of a Precision Medicine Workflow in Hematological Cancers, Aalborg University Hospital, Denmark

Julie Støve Bødker(Chr. Hansen (Denmark)), Martin Bøgsted(Chr. Hansen (Denmark)), Karen Dybkær(Aalborg University Hospital), Anne Stoffersen Rytter(Aalborg University Hospital), Anne Stidsholt Roug(Aalborg University Hospital), Inge Søkilde Pedersen(Aalborg University Hospital), Charles Vesteghem(Aalborg University Hospital), Lykke Grubach(Aalborg University Hospital), Tarec Christoffer El‐Galaly(Aalborg University Hospital), Marianne Tang Severinsen(Aalborg University Hospital), Mads Sønderkær(Aalborg University), Alexander Schmitz(Chr. Hansen (Denmark)), Mia Sommer(Aalborg University Hospital), Paw Jensen(Aalborg University Hospital), Jakob Madsen(Aalborg University Hospital), Rasmus Froberg Brøndum(Aarhus University)

Cancers

January 29, 2020

10.3390/cancers12020312

Cited by 20

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

|Blood|2009|390

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Leukemia|2012|362

Construction of Reference Chromosome-Scale Pseudomolecules for Potato: Integrating the Potato Genome with Genetic and Physical Maps

|G3 Genes Genomes Genetics|2013|286